Red Cell Volume Distribution Width as Another Biomarker

Código QR

Red Cell Volume Distribution Width as Another Biomarker

Guardado en:

Detalles Bibliográficos
Autores principales:	Artemio García-Escobar, Juan Manuel Grande Ingelmo
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2019
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/6152b3818575447e9cd7603a9bf5a5f0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Red Cell Distribution Width as a Biomarker for Heart Failure: Still Not Ready for Prime-Time
por: Sunil K Nadar, et al.
Publicado: (2019)

Using genetics to detangle the relationships between red cell distribution width and cardiovascular diseases: a unique role for body mass index
por: Shi Huang, et al.
Publicado: (2021)

Neprilysin as a Biomarker: Challenges and Opportunities
por: Noemi Pavo, et al.
Publicado: (2020)

Biomarkers in Routine Heart Failure Clinical Care
por: Sunil K Nadar, et al.
Publicado: (2019)

Trending cardiac biomarkers during pregnancy in women with cardiovascular disease
por: Soohyun Chang, et al.
Publicado: (2021)

Mild aortic valve disease and the diastolic pressure–volume relationship in heart failure with preserved ejection fraction
por: Mackram F Eleid, et al.
Publicado: (2021)

Correction to: The association of reduced left ventricular strains with increased extracellular volume and their collective impact on clinical outcomes
por: Chunna Jin, et al.
Publicado: (2021)

Circulating miR-27b as a Biomarker of the Development and Progression of Carotid Artery Stenosis
por: Tingting Lu, et al.
Publicado: (2021)

Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019-associated Acute Respiratory Distress Syndrome: An initial US Experience at a High-volume Centre
por: Yang Yang, et al.
Publicado: (2020)

Novel Cardiovascular Biomarkers Associated with Increased Cardiovascular Risk in Women With Prior Preeclampsia/HELLP Syndrome: A Narrative Review
por: Esmee ME Bovee, et al.
Publicado: (2021)

Rationale and design of the preserved versus reduced ejection fraction biomarker registry and precision medicine database for ambulatory patients with heart failure (PREFER-HF) study
por: James L Januzzi, et al.
Publicado: (2021)

Estimation of plasma volume in patients presenting with acute decompensated heart failure using Kaplan – Hakim formula and correlation of plasma volume shift with outcomes
por: Anil Kumar Singh, et al.
Publicado: (2021)

Predictive Value of Immune Cell Subsets for Mortality Risk in Patients With Sepsis
por: Ying Zhang MM, et al.
Publicado: (2021)

Applications for Induced Pluripotent Stem Cells in Disease Modelling and Drug Development for Heart Diseases
por: Shu Nakao, et al.
Publicado: (2020)

Immune cell subsets as a marker of development of heart failure: The application of bioinformatics tools
por: Mónica Teresa Abreu, et al.
Publicado: (2021)

Immune cell subsets as a marker of development of heart failure: The application of bioinformatics tools
por: Mónica Teresa Abreu, et al.
Publicado: (2021)

Long QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells
por: Luca Sala, et al.
Publicado: (2019)

Coronary Artery Spasm: The Interplay Between Endothelial Dysfunction and Vascular Smooth Muscle Cell Hyperreactivity
por: Astrid Hubert, et al.
Publicado: (2020)

Mechanisms of Cardiotoxicity Associated with Tyrosine Kinase Inhibitors in H9c2 Cells and Mice
por: J Bouitbir, et al.
Publicado: (2020)

Sustained response to targeted therapies in a patient with pulmonary hypertension owing to Langerhans cell histiocytosis
por: Aykun Hakgör, et al.
Publicado: (2021)

Retraction: The Role of Allograft Inflammatory Factor-1 in the Effects of Experimental Diabetes on B Cell Functions in the Heart
por: Frontiers Editorial Office
Publicado: (2021)

Left atrial volume index measurement in STEMI: A prognostic marker
por: Tirthankar Roy, et al.
Publicado: (2021)

Carotid Artery Stenosis and ischemic Strokes in Patients with Giant Cell Arteritis A characteristic Pattern - Literature Review and Case Report
por: Clemens Oerding, et al.
Publicado: (2021)

The Effect of Statins on the Functionality of CD4+CD25+FOXP3+ Regulatory T-cells in Acute Coronary Syndrome: A Systematic Review and Meta-analysis of Randomised Controlled Trials in Asian Populations
por: Nilofer Sorathia, et al.
Publicado: (2019)

Treatment of Coronavirus Disease 2019: Shooting in the Dark
por: Juan Tamargo
Publicado: (2020)

Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments
por: Juan Tamargo
Publicado: (2019)

Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments
por: Juan Tamargo
Publicado: (2019)

Ethical Issues in Decision-making Regarding the Elderly Affected by Coronavirus Disease 2019: An Expert Opinion
por: David Martínez-Sellés, et al.
Publicado: (2020)

Role of High-sensitivity Cardiac Troponin in Acute Coronary Syndrome
por: Mahesh Anantha Narayanan, et al.
Publicado: (2019)

Foreword
por: Juan Carlos Kaski
Publicado: (2019)

Foreword
por: Juan Carlos Kaski
Publicado: (2019)

Foreword
por: Juan Carlos Kaski
Publicado: (2019)

Editorial: The EXCEL Trial
por: Pablo Avanzas, et al.
Publicado: (2021)

The ISCHEMIA Trial: And the Winner Is… the Patient
por: Pablo Avanzas, et al.
Publicado: (2021)

Biomarkers Utility: At the Borderline between Cardiology and Neurology
por: Adriana Ion, et al.
Publicado: (2021)

Destination Therapy with Left Ventricular Assist Devices in Non-transplant Centres: The Time is Right
por: Antoni Bayes-Genis, et al.
Publicado: (2020)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
por: Eliecer Coto, et al.
Publicado: (2021)

Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
por: Tamara García Camarero, et al.
Publicado: (2020)

ISCHEMIA Trial: Key Questions and Answers
por: Jose Lopez-Sendon, et al.
Publicado: (2021)

Insights for Stratification of Risk in Brugada Syndrome
por: Daniel García Iglesias, et al.
Publicado: (2019)